Crinetics Pharmaceuticals, Inc. - Common Stock (CRNX)

267 filings reported holding CRNX - Crinetics Pharmaceuticals, Inc. - Common Stock as of Q3 2024.
Crinetics Pharmaceuticals, Inc. - Common Stock (CRNX) has 232 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC). These institutions hold a total of 84.5M shares of 94.2M outstanding shares and own 89.73% of the company stock.
Largest 10 shareholders include BlackRock, Inc. (6.55M shares), VANGUARD GROUP INC (6.29M shares), Driehaus Capital Management LLC (5.89M shares), PRICE T ROWE ASSOCIATES INC /MD/ (4.94M shares), WELLINGTON MANAGEMENT GROUP LLP (4.46M shares), FMR LLC (4.46M shares), EcoR1 Capital, LLC (4.29M shares), STATE STREET CORP (2.84M shares), JENNISON ASSOCIATES LLC (2.79M shares), and Paradigm Biocapital Advisors LP (2.52M shares).
This table shows the top 232 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.

* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.